Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma. - Wikidata - wikimedia - TriplyDB

Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma.

Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma.

http://www.wikidata.org/entity/Q34249374

about

Prevention of Ovarian Hyperstimulation Syndrome: A Review The myths surrounding mild stimulation in vitro fertilization (IVF)Co-administration of GnRH-agonist and hCG for final oocyte maturation (double trigger) in patients with low number of oocytes retrieved per number of preovulatory follicles--a preliminary report.International regulatory landscape and integration of corrective genome editing into in vitro fertilization.Triggering final follicular maturation--hCG, GnRH-agonist or both, when and to whom?Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy.A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation Ectopic pregnancy risk factors for ART patients undergoing the GnRH antagonist protocol: a retrospective study Herbal Medicines and Ovarian Hyperstimulation Syndrome: A Retrospective Cohort Study HCG (1500IU) administration on day 3 after oocytes retrieval, following GnRH-agonist trigger for final follicular maturation, results in high sufficient mid luteal progesterone levels - a proof of concept.Thrombosis following ovarian hyperstimulation syndrome.Ovarian hyperstimulation syndrome following GnRH agonist trigger-think ectopic.Sliding scale HCG trigger yields equivalent pregnancy outcomes and reduces ovarian hyperstimulation syndrome: Analysis of 10,427 IVF-ICSI cycles.Triggering final follicular maturation-hCG, GnRH-agonist or both, when and to whom?GnRH Antagonist Cetrorelix Administration Before hCG for Protection of Ovarian Hyperstimulation Syndrome.Co-administration of GnRH-agonist and hCG, for final oocyte maturation (double trigger), in patients with low proportion of mature oocytes.Follicular aspiration versus coasting for ovarian hyper-stimulation syndrome prevention.Creating human germ cells for unmet reproductive needs

P2860

Q26828442-6756F7B2-5A28-4B1D-B2F8-5A308F379882 Q33830367-BC281475-4810-484A-84C4-FCD7428A568A Q34544776-6A47BA05-3374-419A-B0DD-C05A4BDD1DDD Q34611496-FEB07C56-F1E7-4834-B514-418B5862C4AE Q35986810-EA08A0FD-A5AD-492D-8955-AB2F0D2F5C2B Q36060453-52FD96EA-ABFB-4020-BD46-E69D9A780AE5 Q36247244-E58EB39D-D2A7-407B-9D1E-50BEFAF95501 Q36720308-7FE13ADF-8810-46BD-BC85-794265BC2EFD Q37263162-B441C506-0652-49EC-87F7-1EAFFDC57800 Q37684179-44AA264D-C0BA-4F00-81A8-48BA65EAB4C1 Q38228426-6929BE8C-2E65-48C4-9200-C2E0CB0D7FFF Q39363519-F1C43CF3-1C8B-4579-BD62-FB163FCDCF41 Q40228612-516D7F97-9C56-4E56-BCD0-4A7EDE366CC7 Q42382814-2CA85A06-F5F8-4764-8953-66C6813D726D Q48517321-DB0957AE-01AD-4250-BA75-0A4AFB567875 Q48591473-8DE11A5E-32A4-4347-B53E-B2E91559C978 Q51739856-49A3D36C-771D-46BD-AAC5-7D90A4F7CBE6 Q57952518-37827405-4541-4321-B60C-CE98C99FD49A

P2860

Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma.

http://www.wikidata.org/entity/Q34249374

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma.

@ast

Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma.

@en

Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma.

@nl

type

label

Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma.

@ast

Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma.

@en

Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma.

@nl

prefLabel

Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma.

@ast

Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma.

@en

Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma.

@nl

P1433

Q34249374-A990B5DE-69AC-4C81-9DAD-78347A1DE2F9

P1476

Q34249374-60F77F5C-C9C1-4B88-AF30-62A8A535B293

P2093

Q34249374-B362ED0D-C679-4E8B-B2F0-203CE921FBDD

P2860

Q34249374-117FAC0D-9359-4582-AE97-281A72A03CE5

Q34249374-3B076EFF-A178-4E90-BEAE-EC2B91402B46

Q34249374-4F32BC5B-29CE-4AFC-A513-392EDE1EC9AD

Q34249374-710B971A-4592-4027-AAE6-8D52AADBA09C

Q34249374-84E3091A-A481-4AF2-B6A2-B4DBA7A23EA9

Q34249374-AC78C7FB-0487-4D7D-9B25-67A04E40A7F3

Q34249374-BB24265B-B585-4A00-BFCD-BAB120491F96

Q34249374-C0327A17-6573-4728-B1E2-2A459B94A662

Q34249374-C34C7A35-C715-491F-A361-4C5016627447

Q34249374-D7383EBA-8E9A-4B5E-A486-B8091A5CAC39

P2888

Q34249374-9B9A234A-CF2B-4576-82B2-C078E0847EFA

P304

Q34249374-7A47E447-BA70-4690-B85B-2C0A207EB400

P31

Q34249374-A64C77BB-996C-403F-9739-A961D3819174

P356

Q34249374-D0A50A0E-E4A3-463F-857A-A4288E337EEB

P433

Q34249374-FF132026-425A-4C80-9F0F-34157B5F933D

P478

Q34249374-40591F36-1E8D-4B61-A120-31524B04B73A

P577

Q34249374-B1BE1F8D-FE25-4B53-9E46-9440208FF4B3

P5875

Q34249374-C424302C-0B43-4657-830C-21E3070163D2

P6179

Q34249374-27A6B2B5-0146-4D8E-80CF-886E854EAFEF

P698

Q34249374-5B732E5A-5A6E-444E-A615-BA55E2B3C28B

P932

Q34249374-08BEB780-04EE-4DAB-873D-661BBDFA4F6D

P356

P1433

Journal of Ovarian Research

P1476

Ovarian hyperstimulation syndrome- an optimal solution for an unresolved enigma.

@en

P2093

Raoul Orvieto

http://www.w3.org/2001/XMLSchema#string

P2860

GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis.

Prediction of ovarian hyperstimulation syndrome. Challenging the estradiol mythos.

Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome.

Can we eliminate severe ovarian hyperstimulation syndrome?

Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment.

An OHSS-Free Clinic by segmentation of IVF treatment.

The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives.

GnRH agonist triggering: recent developments.

Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.

Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicent

P2888

P304

77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1757-2215-6-77

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258312890

http://www.w3.org/2001/XMLSchema#string

P6179

1050528684

http://www.w3.org/2001/XMLSchema#string

P698

24191960

http://www.w3.org/2001/XMLSchema#string

P932

4176292

http://www.w3.org/2001/XMLSchema#string